BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23861552)

  • 1. Krüppel-like factor 2 promotes liver steatosis through upregulation of CD36.
    Chen JL; Lu XJ; Zou KL; Ye K
    J Lipid Res; 2014 Jan; 55(1):32-40. PubMed ID: 23861552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis.
    Lee JH; Wada T; Febbraio M; He J; Matsubara T; Lee MJ; Gonzalez FJ; Xie W
    Gastroenterology; 2010 Aug; 139(2):653-63. PubMed ID: 20303349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperinsulinemia Enhances Hepatic Expression of the Fatty Acid Transporter Cd36 and Provokes Hepatosteatosis and Hepatic Insulin Resistance.
    Steneberg P; Sykaras AG; Backlund F; Straseviciene J; Söderström I; Edlund H
    J Biol Chem; 2015 Jul; 290(31):19034-43. PubMed ID: 26085100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [KLF9 regulates hepatic lipid metabolism via inducing CD36 expression].
    Zhou SS; Zhang YL; Chang YS
    Sheng Li Xue Bao; 2021 Oct; 73(5):772-780. PubMed ID: 34708234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis in ob/ob mice.
    Nassir F; Adewole OL; Brunt EM; Abumrad NA
    J Lipid Res; 2013 Nov; 54(11):2988-97. PubMed ID: 23964120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray analysis of hepatic gene expression identifies new genes involved in steatotic liver.
    Guillén N; Navarro MA; Arnal C; Noone E; Arbonés-Mainar JM; Acín S; Surra JC; Muniesa P; Roche HM; Osada J
    Physiol Genomics; 2009 May; 37(3):187-98. PubMed ID: 19258494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
    Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
    EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis.
    Zhou J; Febbraio M; Wada T; Zhai Y; Kuruba R; He J; Lee JH; Khadem S; Ren S; Li S; Silverstein RL; Xie W
    Gastroenterology; 2008 Feb; 134(2):556-67. PubMed ID: 18242221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARα.
    Lu Y; Liu X; Jiao Y; Xiong X; Wang E; Wang X; Zhang Z; Zhang H; Pan L; Guan Y; Cai D; Ning G; Li X
    J Clin Invest; 2014 Aug; 124(8):3501-13. PubMed ID: 25003192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoprotegerin Promotes Liver Steatosis by Targeting the ERK-PPAR-γ-CD36 Pathway.
    Zhang C; Luo X; Chen J; Zhou B; Yang M; Liu R; Liu D; Gu HF; Zhu Z; Zheng H; Li L; Yang G
    Diabetes; 2019 Oct; 68(10):1902-1914. PubMed ID: 31292134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SRY-Box Containing Gene 4 Promotes Liver Steatosis by Upregulation of SREBP-1c.
    Jiao Y; Zhao J; Zhang Z; Li M; Yu X; Yang Y; Liu J; Liao S; Li D; Wang Y; Zhang D; Chen Y; Shi G; Liu B; Lu Y; Li X
    Diabetes; 2018 Nov; 67(11):2227-2238. PubMed ID: 30181160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinemia activates the aryl hydrocarbon receptor/CD36 pathway to promote hepatic steatosis in mice.
    Yao L; Wang C; Zhang X; Peng L; Liu W; Zhang X; Liu Y; He J; Jiang C; Ai D; Zhu Y
    Hepatology; 2016 Jul; 64(1):92-105. PubMed ID: 26928949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KLF2 (kruppel-like factor 2 [lung]) regulates osteoclastogenesis by modulating autophagy.
    Laha D; Deb M; Das H
    Autophagy; 2019 Dec; 15(12):2063-2075. PubMed ID: 30894058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Krüppel-like factor 2 promotes cell proliferation in hepatocellular carcinoma through up-regulation of c-myc.
    Zou K; Lu X; Ye K; Wang C; You T; Chen J
    Cancer Biol Ther; 2016; 17(1):20-6. PubMed ID: 26853883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of CYP2E1-ROS-CD36/DGAT2 axis in the pathogenesis of VPA-induced hepatic steatosis in vivo and in vitro.
    Ma L; Wang Y; Chen X; Zhao L; Guo Y
    Toxicology; 2020 Dec; 445():152585. PubMed ID: 33007364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIRT1 upregulation protects against liver injury induced by a HFD through inhibiting CD36 and the NF‑κB pathway in mouse kupffer cells.
    Niu B; He K; Li P; Gong J; Zhu X; Ye S; Ou Z; Ren G
    Mol Med Rep; 2018 Aug; 18(2):1609-1615. PubMed ID: 29845302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased placental fatty acid transporter 6 and binding protein 3 expression and fetal liver lipid accumulation in a mouse model of obesity in pregnancy.
    Díaz P; Harris J; Rosario FJ; Powell TL; Jansson T
    Am J Physiol Regul Integr Comp Physiol; 2015 Dec; 309(12):R1569-77. PubMed ID: 26491104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease.
    Bechmann LP; Gastaldelli A; Vetter D; Patman GL; Pascoe L; Hannivoort RA; Lee UE; Fiel I; Muñoz U; Ciociaro D; Lee YM; Buzzigoli E; Miele L; Hui KY; Bugianesi E; Burt AD; Day CP; Mari A; Agius L; Walker M; Friedman SL; Reeves HL
    Hepatology; 2012 Apr; 55(4):1083-93. PubMed ID: 22095588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced levels of microRNAs miR-124a and miR-150 are associated with increased proinflammatory mediator expression in Krüppel-like factor 2 (KLF2)-deficient macrophages.
    Manoharan P; Basford JE; Pilcher-Roberts R; Neumann J; Hui DY; Lingrel JB
    J Biol Chem; 2014 Nov; 289(45):31638-46. PubMed ID: 25248747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.